Park, Chang Hyun
Lee, Hyung Keun
Kim, Mee Kum
Kim, Eun Chul
Kim, Jae Yong
Kim, Tae-im
Kim, Hong Kyun
Song, Jong Suk
Yoon, Kyung Chul
Lee, Do Hyung
Chung, Tae-Young
Choi, Chul Young
Kim, Hyun Seung http://orcid.org/0000-0001-6825-8612
Funding for this research was provided by:
Taejoon Pharm
Article History
Received: 21 January 2019
Accepted: 4 June 2019
First Online: 17 June 2019
Change Date: 23 June 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via the original article.
Ethics approval and consent to participate
: The study was conducted in accordance with the ethical principles specified in the Declaration of Helsinki and Good Clinical Practice Guidelines. This study was approved by the institutional review board (IRB) in each center: Institutional Review Board of Yeouido St. Mary’s Hospital, Gangnam Severance Hospital, Seoul National University Hospital, Bucheon St. Mary’s Hospital, Seoul Asan Medical Center, Severance Hospital, Kyungpook National University Hospital, Korea University Guro Hospital, Chonnam National University Hospital, Ilsan Paik Hospital, Samsung Medical Center and Kangbuk Samsung Hospital. Additionally, this trial was registered on the Current Research Information System (CRIS) () and World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP, ). The trial registration number is KCT0002180. Written informed consent was obtained from each patient prior to participation in the study.
: Not applicable
: The authors declare that they have no competing interests.